ArticleAmerican journal of translational research2025
Efficacy and safety of tympanostomy tube insertion combined with adenoidectomy in children with recurrent otitis media: impact on effusion clearance time, otitis media recurrence rate, and hearing improvement.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate whether adenoidectomy (Ad) combined with tympanostomy tube insertion (TTI) would provide additional benefits for children with recurrent otitis media (ROM).
methodsWe analyzed the medical records of 160 children aged 3 to 10 years who underwent ROM surgery at Guangdong Medical University Panyu He Xian Memorial Hospital between December 2019 and December 2024. These children were divided into two groups according to their treatment regimen: TTI only group (n=64) and TTI + Ad group (n=96). Clinical measures, including tympanic membrane healing, middle ear effusion clearance, as well as complications and recurrent otitis media, were compared between the two groups. Pure tone audiometry and tympanogram were performed at 2 weeks and 6 months postoperatively.
resultsThe TTI + Ad group demonstrated significantly faster middle ear effusion clearance, lower recurrence rate of otitis media, and better improvement in hearing at speech frequency range, compared with the TTI only group. Postoperatively, the tympanogram of TTI + Ad group showed a higher proportion of type A curve, suggesting better middle ear function recovery. Multivariate logistic regression analysis further confirmed that TTI + Ad was a protective factor for treatment failure (OR=0.267) and disease recurrence (OR=0.275).
conclusionThe combination of TTI and Ad is more effective than TTI alone in treating ROM. This combined surgical approach not only facilitates faster clearance of middle ear effusion and reduces the risk of recurrence but also contributes to better recovery of the child's hearing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.